Dr. Bradley Ekstrand graduated the medical school from the Yale University School of Medicine and completed his residency program at the Mount Sinai School of Medicine. A fellowship at the Stanford University followed soon after that. Dr. Ekstrand is specialized in oncology and board certified in internal medicine and medical oncology. He has been in practice for more than 11 years and is affiliated with the Sequoia Hospital. During his career, he has also published four writings of medical interest in collaboration with other doctors.
Mount Sinai School of Medicine
American Board of Internal Medicine
American Board of Internal Medicine - Oncology
Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial.
Ekstrand, B.C., Lucas, J.B., Horwitz, S.M., Fan, Z., Breslin, S., Hoppe, R.T., Natkunam, Y., Bartlett, N.L., Horning, S.J.; Blood. 2003 Jun 1.See more >>
Lymphocyte predominant Hodgkin's disease.
Ekstrand, B.C., Horning, S.J.; Curr Oncol Rep. 2002 Sep.See more >>
Lymphocyte predominant Hodgkin's disease: more patience than patients.
Ekstrand, B.C., Horning, S.J.; Cancer J. 2002-09-01.See more >>
American Society of Clinical Oncology